RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $416,507 | – | 347,089 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $20,239,000 | 3.93% |
| Cormorant Asset Management, LP | 2,326,660 | $29,967,000 | 1.78% |
| BVF INC/IL | 2,957,807 | $38,097,000 | 1.38% |
| Boxer Capital, LLC | 1,175,000 | $15,134,000 | 0.59% |
| Perceptive Advisors | 4,967,238 | $63,978,000 | 0.49% |
| LUMINUS MANAGEMENT LLC | 137,428 | $1,770,000 | 0.42% |
| Logos Global Management LP | 245,161 | $3,158,000 | 0.33% |
| Old Well Partners, LLC | 13,383 | $172,000 | 0.11% |
| Lumina Fund Management LLC | 6,000 | $77,000 | 0.02% |
| Woodline Partners LP | 119,700 | $1,542,000 | 0.02% |